A
Aprea Therapeutics D
D
APRE
1.76000
USD
-0.01
(-0.57%)
مغلق
حجم التداول
209
الربح لكل سهم
-3
العائد الربحي
-
P/E
-1
حجم السوق
9,735,216
الأخبار المقالات
العنوان: Aprea Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.